Axonyx Completes First Phase I Trial with Posiphen for Alzheimer’s Genetic Engineering News, NY - Jan 24, 2006 today completion of the ascending single dose Phase I trial with Posiphen(TM), in clinical development for the treatment of Alzheimer’s disease progression.
Brain Abnormality Found In Alzheimer s Disease Related to Gait [...]
-
Recent Posts
- Understanding Alzheimer’s: How to Help Children Understand Alzheimers Disease
- Healthy Diet Tips for Alzheimer’s Patients
- Explaining the Cause of Alzheimers Disease
- Support for Alzheimer’s Caregivers in Ethnic Communities
- Alzheimers’ Disease Prevention Requires Early Diagnosis
- Steps for Diagnosing Alzheimers in the Elderly
- Denial and Acceptance in Alzheimers Diagnosis
- What is the Definition of Alzheimers Disease?
- Coping with Alzheimers Disease
- Communication Tools for Alzheimers Caregivers
-
Categories
-
Pages
-
Alzheimer’s Disease Articles: